Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.67B | 2.69B | 2.63B | 2.59B | 2.36B | 2.12B | Gross Profit |
1.47B | 1.49B | 1.43B | 1.43B | 1.32B | 1.13B | EBIT |
655.51M | 674.00M | 672.76M | 702.36M | 615.13M | 349.55M | EBITDA |
797.34M | 674.00M | 786.74M | 771.62M | 703.55M | 446.95M | Net Income Common Stockholders |
452.36M | 467.28M | 487.49M | 513.10M | 454.37M | 249.54M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
130.42M | 115.95M | 115.68M | 163.46M | 299.97M | 208.29M | Total Assets |
5.87B | 6.00B | 5.25B | 3.82B | 3.79B | 3.67B | Total Debt |
2.30B | 2.32B | 1.86B | 737.86M | 815.90M | 1.11B | Net Debt |
2.16B | 2.20B | 1.75B | 574.40M | 515.92M | 897.70M | Total Liabilities |
2.99B | 3.07B | 2.65B | 1.53B | 1.63B | 1.92B | Stockholders Equity |
2.88B | 814.42M | 2.60B | 2.29B | 2.16B | 1.76B |
Cash Flow | Free Cash Flow | ||||
464.68M | 491.78M | 606.70M | 461.70M | 507.62M | 451.89M | Operating Cash Flow |
542.96M | 556.19M | 641.28M | 513.13M | 545.93M | 502.42M | Investing Cash Flow |
-852.95M | -844.40M | -1.44B | -222.76M | -33.17M | -194.11M | Financing Cash Flow |
307.40M | 294.50M | 750.51M | -416.01M | -422.91M | -251.53M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $77.81B | 22.63 | 110.24% | 2.19% | -1.30% | 20.26% | |
77 Outperform | $25.53B | 9.57 | 24.30% | 1.10% | -2.99% | 159.26% | |
73 Outperform | $12.04B | 26.94 | 16.15% | 1.38% | 0.78% | -8.42% | |
72 Outperform | $42.68B | 31.22 | 14.97% | 0.61% | 5.22% | 4.46% | |
71 Outperform | $18.44B | 22.99 | 18.28% | 2.45% | 7.45% | 5.43% | |
69 Neutral | $30.74B | 33.83 | 26.22% | 1.88% | -11.28% | -23.69% | |
62 Neutral | $8.11B | 13.34 | 1.17% | 3.02% | 4.16% | -15.14% |
Nordson Corporation reported its fiscal first quarter 2025 results on February 19, 2025, showing a sales decline of 2.8% year-over-year to $615 million, and a decrease in earnings per diluted share to $1.65. Despite weaker sales across multiple end markets, the company saw a 15% growth in backlog and maintained solid operational performance. The company forecasts second-quarter fiscal 2025 sales to range between $650 and $690 million, with adjusted earnings per share expected to be between $2.30 and $2.50, reflecting confidence in overcoming macroeconomic challenges and improving end market demand.
Nordson Corporation reported record fiscal 2024 sales of $2.7 billion, with a 2% growth driven by acquisitions and favorable currency impacts. The company’s Advanced Technology Solutions segment showed positive sales growth, and the recent Atrion Medical acquisition integration contributed positively to results. Looking ahead, Nordson forecasts fiscal 2025 sales to range between $2,750 and $2,870 million, with adjusted earnings per share expected between $9.70 and $10.50. The company is cautiously optimistic, considering the evolving global macro-environment, and plans to maintain operational excellence and strong cash flow through its diversified market focus and close-to-the-customer business model.